Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2026-03-15 @ 9:08 PM
Study NCT ID:
NCT02725112
Status:
COMPLETED
Last Update Posted:
2021-01-20
First Post:
2016-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy Volunteers
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-12
Start Date Type:
ACTUAL
Primary Completion Date:
2016-05-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06-17
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-10
First Submit QC Date:
None
Study First Post Date:
2016-03-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-15
Last Update Post Date:
2021-01-20
Last Update Post Date Type:
ACTUAL